Modus Therapeutics
  • About
    • About us
    • Business Model
    • Team
    • Scientific Advisors
  • Sevuparin
    • About Sevuparin
    • Actions of sevuparin
    • Further reading
  • Research & Development
    • Pipeline
    • About Sepsis
    • About anemia and CKD
    • About severe malaria
    • Sevuparin and sepsis
    • Sevuparin and hepcidin
    • Sevuparin and malaria
  • Investors
    • IPO 2021/ TO1 2022
    • Issues 2023
    • Share
    • News
    • Financial Reports
    • Presentations
    • Calendar
    • Corporate Governance
    • Analyst Coverage
  • News
  • Contact
EN
SV

Investors

Financial Reports
  • IPO 2021/ TO1 2022
  • Issues 2023
  • Share
    • Shareholders
  • News
  • Financial Reports
  • Presentations
  • Calendar
  • Corporate Governance
    • Board
    • Management
  • Analyst Coverage
PRIVACY & TERMS OF USE
© MODUS THERAPEUTICS 2025